1. Home
  2. WSR vs MNKD Comparison

WSR vs MNKD Comparison

Compare WSR & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Whitestone REIT

WSR

Whitestone REIT

HOLD

Current Price

$18.98

Market Cap

973.9M

Sector

Real Estate

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$3.26

Market Cap

877.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WSR
MNKD
Founded
1998
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
973.9M
877.0M
IPO Year
2002
2004

Fundamental Metrics

Financial Performance
Metric
WSR
MNKD
Price
$18.98
$3.26
Analyst Decision
Hold
Buy
Analyst Count
5
8
Target Price
$19.00
$8.69
AVG Volume (30 Days)
372.0K
6.0M
Earning Date
05-01-2026
05-06-2026
Dividend Yield
3.01%
N/A
EPS Growth
31.94
N/A
EPS
0.08
N/A
Revenue
$160,859,000.00
$348,966,000.00
Revenue This Year
$2.77
$35.81
Revenue Next Year
$4.21
$11.89
P/E Ratio
$237.19
N/A
Revenue Growth
4.26
22.23
52 Week Low
$11.43
$2.23
52 Week High
$19.01
$6.51

Technical Indicators

Market Signals
Indicator
WSR
MNKD
Relative Strength Index (RSI) 79.79 57.51
Support Level $18.90 $2.56
Resistance Level $19.00 $6.08
Average True Range (ATR) 0.03 0.25
MACD -0.09 -0.01
Stochastic Oscillator 41.67 31.46

Price Performance

Historical Comparison
WSR
MNKD

About WSR Whitestone REIT

Whitestone REIT is a real estate investment trust (REIT) that owns and operates commercial properties in culturally diverse metropolitan markets. The company's primary business objective is to increase shareholder value by acquiring, owning, and operating Community Centered Properties. Its property portfolio includes retail and mixed-use properties located in business-friendly locations in and around Austin, Scottsdale, Dallas, Houston, Phoenix, Arizona, and San Antonio. The properties are convenience-focused: merchandised with a mix of service-oriented tenants providing food (restaurants and grocers), self-care (health and fitness), services (financial and logistics), education, and entertainment to the surrounding communities.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

Share on Social Networks: